Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Basal Signaling Activity of μ Opioid Receptor in Mouse Brain: Role in Narcotic Dependence

Danxin Wang, Kirsten M. Raehal, Emil T. Lin, John J. Lowery, Brigitte L. Kieffer, Edward J. Bilsky and Wolfgang Sadée
Journal of Pharmacology and Experimental Therapeutics February 2004, 308 (2) 512-520; DOI: https://doi.org/10.1124/jpet.103.054049
Danxin Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten M. Raehal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emil T. Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John J. Lowery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brigitte L. Kieffer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward J. Bilsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Sadée
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Narcotic analgesics cause addiction by poorly understood mechanisms, involving μ opioid receptor (MOR). Previous cell culture studies have demonstrated significant basal, spontaneous MOR signaling activity, but its relevance to narcotic addiction remained unclear. In this study, we tested basal MOR-signaling activity in brain tissue from untreated and morphine-pretreated mice, in comparison to antagonist-induced withdrawal in morphine-dependent mice. Using guanosine 5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding and adenylyl cyclase activity assay in brain homogenates, we demonstrated that morphine pretreatment of mice enhanced basal MOR signaling in mouse brain homogenates and, moreover, caused persistent changes in the effects of naloxone and naltrexone, antagonists that elicit severe withdrawal in dependent subjects. Naloxone and naltrexone suppressed basal [35S]GTPγS binding (acting as “inverse agonists”) only after morphine pretreatment, but not in drug-naive animals. Moreover, naloxone and naltrexone stimulated adenylyl cyclase activity in striatum homogenates only after morphine pretreatment, by reversing the inhibitory effects of basal MOR activity. After cessation of morphine treatment, the time course of inverse naloxone effects on basal MOR signaling was similar to the time course of naltrexone-stimulated narcotic withdrawal over several days. The neutral antagonist 6β-naltrexol blocked MOR activation without affecting basal signaling (G protein coupling and adenylyl cyclase regulation) and also elicited substantially less severe withdrawal. These results demonstrate long-lasting regulation of basal MOR signaling as a potential factor in narcotic dependence.

Footnotes

  • This study was supported by National Institute on Drug Abuse Grants DA 04166 and DA 06284, a grant from the Wheeler Center for Neurobiology of Addiction, University of California San Francisco, and funds from the College of Medicine and Public Health, Ohio State University. J.J.L. received support from a Summer Undergraduate Research Fellowship from the American Society for Pharmacology and Experimental Therapeutics and a Maine Space Grant Consortium Fellowship.

  • DOI: 10.1124/jpet.103.054049.

  • ABBREVIATIONS: MOR, μ opioid receptor; BNTX, 7-benzylidenenaltrexone; NIDA, National Institute on Drug Abuse; DAMGO, [d-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin; β-CNA, β-chlornaltrexamine; ICI 174,864, N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH; [35S]GTPγS, guanosine 5′-O-(3-[35S]thio)triphosphate; DTT, dithiothreitol.

    • Received May 6, 2003.
    • Accepted October 31, 2003.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 308 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 308, Issue 2
1 Feb 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Basal Signaling Activity of μ Opioid Receptor in Mouse Brain: Role in Narcotic Dependence
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Basal Signaling Activity of μ Opioid Receptor in Mouse Brain: Role in Narcotic Dependence

Danxin Wang, Kirsten M. Raehal, Emil T. Lin, John J. Lowery, Brigitte L. Kieffer, Edward J. Bilsky and Wolfgang Sadée
Journal of Pharmacology and Experimental Therapeutics February 1, 2004, 308 (2) 512-520; DOI: https://doi.org/10.1124/jpet.103.054049

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleNEUROPHARMACOLOGY

Basal Signaling Activity of μ Opioid Receptor in Mouse Brain: Role in Narcotic Dependence

Danxin Wang, Kirsten M. Raehal, Emil T. Lin, John J. Lowery, Brigitte L. Kieffer, Edward J. Bilsky and Wolfgang Sadée
Journal of Pharmacology and Experimental Therapeutics February 1, 2004, 308 (2) 512-520; DOI: https://doi.org/10.1124/jpet.103.054049
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • P-Glycoprotein Apical Efflux Ratio for Compound Optimization
  • Pharmacology of Carbamate Insecticides at Melatonin Receptors
  • Metalloporphyrins modify disease outcomes in parkinsonism
Show more Neuropharmacology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics